Dr. Lal Pathlabs Ltd has moved from a long-term downtrend towards a potential uptrend using Wyckoff structure analysis, according to SEBI-registered analyst Harshit Goel. According to Goel, the stock ...

BENGALURU, May 11 (Reuters) - India's Dr. Lal PathLabs Ltd (DLPA.NS), opens new tab on Thursday reported a sixth consecutive fall in quarterly profit as a continued slide in income from COVID-related ...

Dr Lal PathLabs on Friday announced its Q3 results, reporting a year-on-year increase in revenue while net profit declined. Dr Lal PathLabs on Friday announced its Q3 results. Image Credit: Freepik Dr ...

Dr. Lal Path Labs posts earnings dip on Indian labour code changes; test demand strong Dr. Lal Path Labs reported a lower third-quarter profit on Friday after taking a one-time charge linked to ...

Dr Lal PathLabs is set to see a sharp decline in its quoted share price on Friday, December 19, as the stock turned ex-date for its maiden bonus issue. Today is also the record date for the corporate ...

Dr. Lal PathLabs is lining up a decisive acquisition drive to consolidate India’s hyper‑local diagnostics market, with Group CFO and International CEO Ved Goel signalling that the company is now “a ...